Filter the drugs by their COVID-19 status ,phase of research and how they help

COVID-19 is a respiratory disease caused by the SARS-CoV-2 virus. Browse the database of potential drugs for COVID-19 treatment compiled by the AIM tool.
Substance COVID-19 status Phase of research How it helps Latest publication
Ritonavir
Cathepsin B
Emergency use authorization Used to treat other disease Antiviral Nov/02/2021
Dacomitinib
Cathepsin B
Potential treatment - pre-clinical evidence Used to treat other disease Antiviral Mar/23/2021
Indinavir
Cathepsin B
Potential treatment - theoretical effect Used to treat other disease Antiviral Mar/07/2021
Boceprevir
Cathepsin B
Potential treatment - pre-clinical evidence Used to treat other disease Antiviral Mar/01/2021
Atazanavir
Cathepsin B
Potential treatment - pre-clinical evidence Used to treat other disease Antiviral Nov/26/2020
(-)-Epicatechin
Cathepsin B
Potential treatment - theoretical effect Natural product Antiviral Oct/28/2020
Neratinib
Cathepsin B
Potential treatment - theoretical effect Used to treat other disease Antiviral Aug/26/2020
(E)-N-[4-[3-Chloro-4-[(3-fluorophenyl)methoxy]anilino]-3-cyano-7-ethoxyquinolin-6-yl]-4-(dimethylamino)but-2-enamide
Cathepsin B
Potential treatment - theoretical effect Experimental Antiviral Aug/26/2020